289 related articles for article (PubMed ID: 21622249)
21. Podocyte injury: the role of proteinuria, urinary plasminogen, and oxidative stress.
Raij L; Tian R; Wong JS; He JC; Campbell KN
Am J Physiol Renal Physiol; 2016 Dec; 311(6):F1308-F1317. PubMed ID: 27335373
[TBL] [Abstract][Full Text] [Related]
22. Glomerular sclerosis is prevented during urinary tract obstruction due to podocyte protection.
Matsusaka T; Kobayashi K; Kon V; Pastan I; Fogo AB; Ichikawa I
Am J Physiol Renal Physiol; 2011 Mar; 300(3):F792-800. PubMed ID: 21177778
[TBL] [Abstract][Full Text] [Related]
23. [The role of podocyte injury in chronic kidney disease].
Asanuma K
Nihon Rinsho Meneki Gakkai Kaishi; 2015; 38(1):26-36. PubMed ID: 25765686
[TBL] [Abstract][Full Text] [Related]
24. Podocytes and glomerular function with aging.
Wiggins J
Semin Nephrol; 2009 Nov; 29(6):587-93. PubMed ID: 20006790
[TBL] [Abstract][Full Text] [Related]
25. Podocyte injury underlies the glomerulopathy of Dahl salt-hypertensive rats and is reversed by aldosterone blocker.
Nagase M; Shibata S; Yoshida S; Nagase T; Gotoda T; Fujita T
Hypertension; 2006 Jun; 47(6):1084-93. PubMed ID: 16636193
[TBL] [Abstract][Full Text] [Related]
26. Podocyte depletion causes glomerulosclerosis: diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene.
Wharram BL; Goyal M; Wiggins JE; Sanden SK; Hussain S; Filipiak WE; Saunders TL; Dysko RC; Kohno K; Holzman LB; Wiggins RC
J Am Soc Nephrol; 2005 Oct; 16(10):2941-52. PubMed ID: 16107576
[TBL] [Abstract][Full Text] [Related]
27. RAGE mediates podocyte injury in adriamycin-induced glomerulosclerosis.
Guo J; Ananthakrishnan R; Qu W; Lu Y; Reiniger N; Zeng S; Ma W; Rosario R; Yan SF; Ramasamy R; D'Agati V; Schmidt AM
J Am Soc Nephrol; 2008 May; 19(5):961-72. PubMed ID: 18256352
[TBL] [Abstract][Full Text] [Related]
28. How many ways can a podocyte die?
Tharaux PL; Huber TB
Semin Nephrol; 2012 Jul; 32(4):394-404. PubMed ID: 22958494
[TBL] [Abstract][Full Text] [Related]
29. Focal segmental glomerulosclerosis; why does it occur segmentally?
Nagata M; Kobayashi N; Hara S
Pflugers Arch; 2017 Aug; 469(7-8):983-988. PubMed ID: 28664408
[TBL] [Abstract][Full Text] [Related]
30. Medium from mesangial cells incubated with aggregated IgA1 from IgA nephropathy patients reduces podocyte adhesion through activation of the renin angiotensin system.
Wang C; Liu X; Tang Y; Peng H; Ye Z; Zhang J; Tang H; Lou T
Swiss Med Wkly; 2011; 141():w13304. PubMed ID: 22252673
[TBL] [Abstract][Full Text] [Related]
31. CXCL12 blockade preferentially regenerates lost podocytes in cortical nephrons by targeting an intrinsic podocyte-progenitor feedback mechanism.
Romoli S; Angelotti ML; Antonelli G; Kumar Vr S; Mulay SR; Desai J; Anguiano Gomez L; Thomasova D; Eulberg D; Klussmann S; Melica ME; Conte C; Lombardi D; Lasagni L; Anders HJ; Romagnani P
Kidney Int; 2018 Dec; 94(6):1111-1126. PubMed ID: 30385042
[TBL] [Abstract][Full Text] [Related]
32. Activation of a local renin angiotensin system in podocytes by glucose.
Durvasula RV; Shankland SJ
Am J Physiol Renal Physiol; 2008 Apr; 294(4):F830-9. PubMed ID: 18216149
[TBL] [Abstract][Full Text] [Related]
33. CDK inhibitor p21 is prosurvival in adriamycin-induced podocyte injury, in vitro and in vivo.
Marshall CB; Krofft RD; Pippin JW; Shankland SJ
Am J Physiol Renal Physiol; 2010 May; 298(5):F1140-51. PubMed ID: 20130121
[TBL] [Abstract][Full Text] [Related]
34. Protecting Podocytes: A Key Target for Therapy of Focal Segmental Glomerulosclerosis.
Campbell KN; Tumlin JA
Am J Nephrol; 2018; 47 Suppl 1(Suppl 1):14-29. PubMed ID: 29852493
[TBL] [Abstract][Full Text] [Related]
35. [Abnormality of renin-angiotensin system in podocyte dysfunction in diabetic kidney disease].
Shao DC; Lu LM
Sheng Li Ke Xue Jin Zhan; 2011 Aug; 42(4):246-50. PubMed ID: 22066414
[TBL] [Abstract][Full Text] [Related]
36. Cells of renin lineage take on a podocyte phenotype in aging nephropathy.
Pippin JW; Glenn ST; Krofft RD; Rusiniak ME; Alpers CE; Hudkins K; Duffield JS; Gross KW; Shankland SJ
Am J Physiol Renal Physiol; 2014 May; 306(10):F1198-209. PubMed ID: 24647714
[TBL] [Abstract][Full Text] [Related]
37. Renin-angiotensin system within the diabetic podocyte.
Márquez E; Riera M; Pascual J; Soler MJ
Am J Physiol Renal Physiol; 2015 Jan; 308(1):F1-10. PubMed ID: 25339703
[TBL] [Abstract][Full Text] [Related]
38. Role of RAS/Wnt/β-catenin axis activation in the pathogenesis of podocyte injury and tubulo-interstitial nephropathy.
Chen L; Chen DQ; Wang M; Liu D; Chen H; Dou F; Vaziri ND; Zhao YY
Chem Biol Interact; 2017 Aug; 273():56-72. PubMed ID: 28578904
[TBL] [Abstract][Full Text] [Related]
39. A multicolor podocyte reporter highlights heterogeneous podocyte changes in focal segmental glomerulosclerosis.
Tao J; Polumbo C; Reidy K; Sweetwyne M; Susztak K
Kidney Int; 2014 Apr; 85(4):972-80. PubMed ID: 24284512
[TBL] [Abstract][Full Text] [Related]
40. Functional expression of the renin-angiotensin system in human podocytes.
Liebau MC; Lang D; Böhm J; Endlich N; Bek MJ; Witherden I; Mathieson PW; Saleem MA; Pavenstädt H; Fischer KG
Am J Physiol Renal Physiol; 2006 Mar; 290(3):F710-9. PubMed ID: 16189286
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
